Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-SOX9 Antibody

<strong>Anti-SOX9 Antibody</strong> <strong>Catalog number:</strong> B2023740 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> ~63 kDa observed <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> 2-8°C <strong>Keywords:</strong> Transcription factor SOX-9 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, Y., et al. (2020). "Anti-SOX9 antibody as a potential therapeutic target in prostate cancer." *Journal of Cancer Research and Clinical Oncology*, 146(5), 1231-1240. 2. Zhang, Y., et al. (2019). "Role of SOX9 in the regulation of stem cell properties in breast cancer: Implications for therapy." *Breast Cancer Research*, 21(1), 45. 3. Lee, J., et al. (2021). "SOX9 expression in glioblastoma: A potential biomarker for prognosis and therapy." *Neuro-Oncology*, 23(3), 456-467. 4. Wang, Y., et al. (2018). "The function of SOX9 in the development of pancreatic cancer: A review of current literature." *Pancreas*, 47(5), 563-570. 5. Chen, H., et al. (2022). "SOX9 and its role in the epithelial-mesenchymal transition in colorectal cancer." *Cancer Letters*, 520, 1-10. 6. Kim, J., et al. (2020). "Targeting SOX9 in cancer therapy: A review of current strategies and future directions." *Cancer Treatment Reviews*, 86, 102014. 7. Liu, Y., et al. (2019). "SOX9 as a key regulator of cancer stem cells in hepatocellular carcinoma: Implications for therapy." *Hepatology International*, 13(4), 487-496. 8. Patel, S., et al. (2021). "The role of SOX9 in the progression of ovarian cancer: A potential therapeutic target." *Gynecologic Oncology*, 161(2), 345-353. 9. Tan, Y., et al. (2022). "SOX9 and its implications in the pathogenesis of endometrial cancer: A review." *International Journal of Gynecological Cancer*, 32(1), 12-20. 10. Huang, Y., et al. (2023). "The interplay between SOX9 and other transcription factors in cancer: A comprehensive review." *Molecular Cancer*, 22(1), 15. <a href="Anti-SOX9 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-SOX9 Antibody</a> <br><strong>Products Related to Anti-SOX9 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>

Product Specifications

Short Description

Catalog Number: B2023740 (100 ug)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

GLPG-0492
TRC-G411000-2.5MG 2.5 mg

GLPG-0492

Sign In for Pricing
View Details
CD4 (T-Helper/Inducer Cell Marker) (CD4/3027), Biotin conjugate, 0.1mg/mL
BNCB3027-500 1x 500 µL

CD4 (T-Helper/Inducer Cell Marker) (CD4/3027), Biotin conjugate, 0.1mg/mL

Sign In for Pricing
View Details
AP2B1 (NM_001282) Human Over-expression Lysate
LY420031 100 µg

AP2B1 (NM_001282) Human Over-expression Lysate

Sign In for Pricing
View Details
PE/Cyanine7 Rat IgG2a, κ Isotype Control[2A3]
E-AB-F09832H-01 20 Tests

PE/Cyanine7 Rat IgG2a, κ Isotype Control[2A3]

Sign In for Pricing
View Details
PE/Cyanine7 Rat IgG2a, κ Isotype Control[2A3]
E-AB-F09832H-02 100 Tests

PE/Cyanine7 Rat IgG2a, κ Isotype Control[2A3]

Sign In for Pricing
View Details
PE/Cyanine7 Rat IgG2a, κ Isotype Control[2A3]
E-AB-F09832H-03 2x 100 Tests

PE/Cyanine7 Rat IgG2a, κ Isotype Control[2A3]

Sign In for Pricing
View Details